NuVasive Gains FDA Clearance for Monolith Corpectomy

NuVasive received FDA 510(k) clearance to market an expanded indication for use of its Monolith® modular PEEK corpectomy system in the cervical spine to treat damage caused by fracture, tumors and osteomyelitis or to support reconstruction following corpectomy performed to achieve decompression of the spinal cord and neural tissue in cervical...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us